SCHEMBL6731241

SCHEMBL6731241

O=C(c1ccccn1)N(CCN1CCCC1)CC1=CC(c2ccc3[nH]ccc3c2)=CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTNNB1 P35222 1/20 0.40
▸ WNT3A P56704 1/20 0.40
▸ OPRK1 P41145 7/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ GAA P10253 2/20 0.37
▸ ROCK2 O75116 1/20 0.36
▸ ROCK1 Q13464 1/20 0.36
▸ LTA4H P09960 1/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MAP3K11 Q16584 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ SRPK1 Q96SB4 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6731153 0.83 CTNNB1 (0.41) CTNNB1WNT3AOPRK1KDM4EGAA
SCHEMBL13604944 0.82 CTNNB1 (0.40) CTNNB1WNT3AOPRK1KDM4EGAA
SCHEMBL13604926 0.79 ROCK2 (0.43) CTNNB1WNT3AOPRK1KDM4EGAA
SCHEMBL6730552 0.78 OPRK1 (0.41) CTNNB1WNT3AOPRK1KDM4EGAA
SCHEMBL10269438 0.77 OPRK1 (0.40) CTNNB1WNT3AOPRK1KDM4EGAA
SCHEMBL6730751 0.76 OPRK1 (0.39) CTNNB1WNT3AOPRK1KDM4EGAA
SCHEMBL3703447 0.71 LTA4H (0.38) CTNNB1WNT3AROCK2ROCK1LTA4H
SCHEMBL3695817 0.71 ROCK2 (0.49) ROCK2ROCK1LTA4H
SCHEMBL3695681 0.69 ROCK2 (0.40) ROCK2ROCK1LTA4HMAP3K11CHEK1
SCHEMBL3696781 0.69 LTA4H (0.37) CTNNB1WNT3AROCK2ROCK1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851199-B1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS AVENTIS PHARMA INC (US) 2012-05-16 — — EP disclosed
Send feedback